OMAHA, Neb., Nov. 7 /PRNewswire-FirstCall/ -- Transgenomic Inc. announces the following Webcast:
What: Transgenomic Inc. Third Quarter 2005 Earnings Release Conference Call When: 11/8/05 @ 5:00 p.m. Eastern Where: http://phx.corporate-ir.net/playerlink.zhtml?c=120897&s=wm&e=1161172 How: Live over the Internet -- Simply log on to the web at the address above. Contact: Mitchell L. Murphy, Investor Relations, 402-452-5418, or mmurphy@transgenomic.com
To access the call via telephone, call 800-362-0571. A replay of the call will be available via the telephone until 11:59 pm EST on November 22, 2005. To access, dial 888-269-5322 or 402-220-7324.
About Transgenomic
Transgenomic is a global company that markets and sells versatile and innovative products and related services to the medical research and pharmaceutical markets for use in genetic variation analysis. The company’s WAVE System, with over 1200 installed in more than thirty countries, has broad applicability to genetic research and molecular diagnostics. Transgenomic also provides genomic biomarker analysis services to pharmaceutical and biopharmaceutical companies to support preclinical and clinical development of targeted therapeutics. The high sensitivity of the WAVE System in detecting genetic variation makes it a uniquely enabling technology for the advancement of personalized medicine. For more information please visit the company’s Web site at www.transgenomic.com.
(Minimum Requirements to listen to broadcast:
The Windows Media Player software, downloadable free from http://www.microsoft.com/windows/windowsmedia/mp10/default.aspx and at least a 28.8 kbps connection to the Internet.)
Transgenomic Inc.
CONTACT: Investor Relations, Mitchell L. Murphy of Transgenomic Inc.,+1-402-452-5418, mmurphy@transgenomic.com
Web site: http://www.transgenomic.com/
